XML 27 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 23,872 $ 27,273
Trade and other receivables, net 8,471 4,704
Inventories, net 6,769 5,780
Prepaid expenses and other current assets 1,854 2,131
Total current assets 40,966 39,888
Property and equipment, net 4,179 4,085
Right-of-use assets, net 5,557 5,211
Intangible assets, net 1,278 1,435
Other non-current assets 5,438 6,451
Total assets 57,418 57,070
Current liabilities:    
Accounts payable 8,926 9,946
Accrued expenses 6,497 7,967
Lease liabilities, current 390 255
Deferred revenue 1,551 1,513
Liability related to the sale of future revenue, current 922 1,147
Notes payable, current 22 18,700
Total current liabilities 18,308 39,528
Notes payable, net 27,508 33,448
Royalty obligations, net 14,761 0
Liability related to the sale of future revenue, net 63,568 64,112
Lease liabilities 5,399 5,085
Deferred revenue, net of current portion 32,345 31,417
Other non-current liabilities 2,016 2,034
Total liabilities 163,905 175,624
Contingencies (Note 22)
Stockholders’ deficit:    
Common stock, 0.001 par value. Authorized 250,000,000 shares; 68,533,085 and 54,827,734 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively 69 55
Additional paid-in capital 212,521 192,598
Accumulated deficit (319,077) (311,207)
Total stockholders’ deficit (106,487) (118,554)
Total liabilities and stockholders’ deficit $ 57,418 $ 57,070